Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2002, p. 4729-4731, Vol. 40, No. 12
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.12.4729-4731.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Section of Parasitology, Department of Medical Microbiology,1 Department of Clinical Chemistry,2 Department of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands3
Received 5 March 2002/ Returned for modification 29 May 2002/ Accepted 23 July 2002
|
|
|---|
0.5%. Attention to these abnormalities in medical centers without tropical disease expertise may decrease a delay in the diagnosis of malaria. |
|
|---|
We prospectively studied 113 patients referred to the Section of Parasitology because of clinical suspicions of malaria by the Emergency Department or the Tropical Disease Center of the Academic Medical Center, Amsterdam, The Netherlands. Malaria was considered part of the differential diagnosis of pyrexia when a patient presented with a travel history to an area where malaria is endemic. Routine malaria analysis consisted of examination of stained thick and thin blood smears according to World Health Organization standard methods and quantitative buffy coat analysis. If malaria parasites were observed and a parasite density of
0.5% was expected, parasite density was expressed as the percentage of erythrocytes infected by determining in duplo the number of infected erythrocytes per 2,000 erythrocytes on a thin blood smear. In the case of an expected parasite density of <0.5%, parasite density was determined by counting in duplicate the number of parasites observed per 100 white blood cells on a thick blood smear. Species identification was based on morphological features. In addition, full blood count and reticulocyte analyses were performed at the Department of Clinical Chemistry with EDTA-anticoagulated blood on the Cell-Dyn 4000 hematology analyzer. Details of this technology have been described previously (2, 4). The presence of depolarizing monocytes was defined as the presence in a lobularity-granularity plot of any depolarizing purple event situated above a separation line constructed from a line making a 22.5° angle with the x axis and a horizontal line through granularity signal channel 25 (C. S. Scott, Abbott Diagnostics, Maidenhead, Berkshire, United Kingdom, personal communication) (Fig. 1A and B). Pseudoreticulocytosis was defined as a distinct spike with narrow fluorescence intensity in a reticulocyte histogram (Fig. 1C and D). Laboratory technicians at the Parasitology Section and the Department of Clinical Chemistry were blind to results obtained in the other laboratory.
![]() View larger version (24K): [in a new window] |
FIG. 1. Differential white blood cell plots and reticulocyte histograms generated by the Cell-Dyn 4000 hematology analyzer from the peripheral blood of patients with and without malaria. (A) Differential lobularity-granularity plot of the white blood cells from a patient without malaria. Monocytes are shown in purple, lymphocytes are shown in blue, neutrophils are shown in orange, eosinophils are shown in green, and basophils are shown in black. The differential lobularity-granularity plot depicts the results of a lobularity analysis (90° lobularity) versus those of a depolarization analysis (90° depolarized granularity [90DGRNLRTY]). (B) Lobularity-granularity plot of a patient with P. falciparum malaria. Note the presence of hemozoin-containing depolarizing monocytes as purple dots above the separation line (see arrow). (C and D) Reticulocyte histograms (RETC) of a patient without malaria (C) and of a patient with P. falciparum malaria (D). Note the presence of a distinct fluorescent spike representing nuclear material of intraerythrocytic malaria parasites (arrow). FL1, fluorescence intensity.
|
0.5% and 21 had parasitemia levels of <0.5%. Non-falciparum malaria was detected in 12 patients (5 P. vivax cases, 4 P. ovale cases, and 3 cases in which no differentiation could be made between P. vivax and P. ovale). Table 1 presents findings with the Cell-Dyn 4000 hematology analyzer for the 113 analyzed patients. Overall, either depolarizing monocytes or pseudoreticulocytosis was observed in 36 of 58 malaria patients (62%) and in 2 of 55 patients without malaria (4%). In the subgroup of P. falciparum malaria patients with parasitemia levels of
0.5%, either depolarizing monocytes or pseudoreticulocytosis was observed in 24 of 25 patients (96%). A statistically significant difference (unpaired t test, P = 0.03, SPSS software version 10.0) in mean durations of symptoms before presentation for malaria analysis was present among the 29 malaria patients in which depolarizing monocytes were detected (4.5 days; 95% confidence interval, 3.7 to 5.4) and the 29 malaria patients in which these cells were not detected (3.2 days; 95% confidence interval, 2.4 to 4.0). Mean levels of parasitemia as detected by routine malaria analysis did not differ between these two groups. |
View this table: [in a new window] |
TABLE 1. Findings with the Cell-Dyn 4000 hematology analyzer for 113 patients with or without malaria infectiona
|
Pseudoreticulocytosis was observed almost exclusively in P. falciparum malaria patients with parasitemia levels of
0.5%. One P. falciparum malaria patient with a parasitemia level of 0.4% presented with pseudoreticulocytosis, while three P. falciparum malaria patients with parasitemia levels of 0.5, 0.5, and 0.6% did not exhibit this phenomenon. This indicates that a parasitemia level around 0.5% is a cutoff point for pseudoreticulocytosis to appear. Pseudoreticulocytosis did not occur in non-falciparum malaria patients. Parasitemia levels in non-falciparum malaria patients are low and might, in general, be below the detection level of the Cell-Dyn 4000 technique. In addition, it is known that P. vivax preferentially infects reticulocytes. P. vivax-infected reticulocytes will be detected by the Cell-Dyn 4000 hematology analyzer as true reticulocytes. In theory, therefore, they might not contribute to the pseudoreticulocytosis phenomenon.
In their initial report on the detection of depolarizing monocytes in areas where malaria is endemic, Mendelow et al. reported sensitivities for black and white patients in South Africa of 90 and 42%, respectively, using the Cell-Dyn 3500 hematology analyzer. The reason for this racial difference was not found, but speculations were made regarding certain genetic factors, previous exposure, or different responses to infection (4). We show that in imported malaria, the presence or absence of depolarizing monocytes detectable by the Cell-Dyn 4000 hematology analyzer depends on the duration of symptoms before presentation for malaria analysis. Thus, the difference in sensitivities for black and white malaria patients in the South African study may reflect socioeconomic or cultural differences in access to health services and, therefore, in duration of symptoms before presentation for malaria analysis.
Recently, a Canadian study reported on the diagnosis and management of imported malaria in medical centers whose technicians lack expertise in tropical medicine versus the diagnosis and management in medical centers with a tropical disease unit. There were significant delays in the recognition, laboratory diagnosis, and initiation of treatment of malaria when patients presented to medical centers where technicians lacked expertise in tropical medicine (3). Although the Cell-Dyn 4000 hematology analyzer has a low sensitivity for the detection of malaria, the specificity is high. Therefore, it is feasible that the Cell-Dyn 4000 hematology analyzer may contribute to the diagnosis of imported malaria in medical centers whose technicians lack expertise in tropical medicine. As it is likely that general screening tests like a full blood count are always undertaken for patients who present with pyrexia, it can be expected that attention to these abnormalities can decrease a delay in the diagnosis of severe P. falciparum malaria if such a diagnosis was not initially considered. However, our data also indicate that one should not rely on the Cell-Dyn 4000 hematology analyzer as the sole diagnostic test for malaria. A good patient history and repeated routine malaria analysis are essential, especially for patients suspected of being early in the course of a P. falciparum infection.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»